Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.

Chia Yin ChongRina Y-L OngValerie X-F SeahNatalie W-H TanMei-Yoke ChanShui-Yen SohChristina OngAshley S LimKoh-Cheng Thoon

Published in: Journal of paediatrics and child health (2019)

TCS usage was highly successful in CLABSI reduction by 80% in all patients, 90% in H/O and 70% in GI patients. In patients with high baseline CLABSI rates, TCS is an effective catheter-lock therapy to reduce CLABSI rates in paediatric patients.

Keyphrases

end stage renal disease
newly diagnosed
emergency department
peritoneal dialysis
intensive care unit
prognostic factors
escherichia coli
bone marrow
smoking cessation